Legal & General Group Plc - CASI PHARMACEUTICALS INC ownership

CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 60 filers reported holding CASI PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of CASI PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$17,000
-29.2%
6,908
-14.3%
0.00%
Q4 2020$24,000
+100.0%
8,0620.0%0.00%
Q3 2020$12,000
-42.9%
8,062
-5.5%
0.00%
Q2 2020$21,000
+23.5%
8,528
+0.4%
0.00%
Q1 2020$17,000
-51.4%
8,493
-24.0%
0.00%
Q4 2019$35,000
+40.0%
11,180
+50.2%
0.00%
Q3 2019$25,000
+4.2%
7,4420.0%0.00%
Q2 2019$24,000
+14.3%
7,4420.0%0.00%
Q1 2019$21,000
-30.0%
7,4420.0%0.00%
Q4 2018$30,000
-14.3%
7,4420.0%0.00%
Q3 2018$35,000
-42.6%
7,4420.0%0.00%
Q2 2018$61,0007,4420.00%
Other shareholders
CASI PHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Wellington Shields Capital Management, LLC 2,188,547$1,751,0000.22%
Wellington Shields & Co., LLC 1,141,190$913,0000.18%
Ikarian Capital, LLC 1,223,067$978,0000.15%
Ground Swell Capital, LLC 18,638$15,0000.09%
Anson Funds Management LP 267,507$214,0000.02%
Sterneck Capital Management, LLC 40,000$32,0000.02%
FEDERATED HERMES, INC. 10,150,000$8,120,0000.02%
Roundview Capital LLC 122,453$98,0000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 1,677,146$1,342,0000.01%
RBF Capital, LLC 159,367$127,0000.01%
View complete list of CASI PHARMACEUTICALS INC shareholders